title: The longest stalk: preserved pituitary function after regression of a giant prolactinoma.
authors.affiliation: University of Virginia Health System, Charlottesville, VA, 22908, USA. jlundgren@virginia.edu.
authors.forename: Jessica A
authors.initials: JA
authors.lastname: Lundgren
authors.affiliation: University of Virginia Health System, Charlottesville, VA, 22908, USA.
authors.forename: Edward H
authors.initials: EH
authors.lastname: Oldfield
authors.affiliation: University of Virginia Health System, Charlottesville, VA, 22908, USA.
authors.forename: John C
authors.initials: JC
authors.lastname: Marshall
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002277:Carcinoma / Q000175:diagnosis / Q000503:physiopathology / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000556:secondary; D009929:Organ Size; D010901:Pituitary Function Tests; D010902:Pituitary Gland / Q000473:pathology / Q000502:physiology* / Q000503:physiopathology; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D015175:Prolactinoma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D012074:Remission Induction; D047368:Tumor Burden / Q000187:drug effects
chemical_list: D002945:Cisplatin; D005472:Fluorouracil